NCT07133477 A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function
| NCT ID | NCT07133477 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Epax Norway AS |
| Condition | Skin Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-04-30 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-04-30 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function. Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.
Eligibility Criteria
Inclusion Criteria: * Volunteers who are able to provide signed informed consent * Healthy male or female volunteers between the ages of 35 and 65 years * Volunteers with a self-perceived history of atopic skin, prone to redness and/or dryness Exclusion Criteria: * Females who are pregnant, breast feeding, or have given birth within the previous 6 weeks or are planning to be pregnant during the study * Volunteers with previous experience of intolerance or allergic reactions to fish or fish products * Volunteers with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of a trained assessor or dermatologist may affect the test results * Volunteers currently taking or who have recently taken antihistamines, antibiotics, systemic anti-inflammatory drugs during the previous week * Volunteers currently taking or who have recently taken retinoids, immunosuppressive drugs, anti-cancer drugs during the six previous months * Volunteers who have started, stopped or changed hormonal treatment (including contraceptive pills) in the five previous weeks * Volunteers whose skin has been exposed to excessive levels of sun or UV rays during the previous month * Volunteers who are suffering from chronic asthma, a malfunction of the lymphatic system, or an auto immune deficiency disease (e.g. lupus, thyroiditis) * Volunteers with a history of skin tumours or malignant disease * Volunteers who have participated in any clinical study involving the test sites within the previous month * Volunteers taking fish oil supplements or other lipid-based supplements regularly during the last 4 weeks
Frequently Asked Questions
Who can join the NCT07133477 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 65 Years, studying Skin Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07133477 currently recruiting?
Yes, NCT07133477 is actively recruiting participants. Visit ClinicalTrials.gov or contact Epax Norway AS to inquire about joining.
Where is the NCT07133477 trial being conducted?
This trial is being conducted at Cardiff, United Kingdom.
Who is sponsoring the NCT07133477 clinical trial?
NCT07133477 is sponsored by Epax Norway AS. The trial plans to enroll 90 participants.